SAF Stops Use of Usual Anti-Malaria Drug (Singapore)
This article was originally published in PharmAsia News
Executive Summary
The death of a Singapore solider due to an allergic reaction to the anti-malaria drug Maloprim has caused that country's army to cease handing it out as its typical medication. Maloprim is no longer given to Singapore solders before training in regions laden with mosquitoes in Singapore or overseas. Since April 2006, two different drugs have been handed out instead. The soldier who died from the maloprim reaction--Muhammad Sufian Jamil--experienced blood poisoning and multiple-organ failure after taking numerous doses of Maloprim between December 2005 and January 2006. Since 1985, 20,000 to 30,000 soldiers have taken maloprim annually without fatalities. Sufian, however, had an unusual condition known as Dapsone hypersensitivity syndrome, which no one knew about. The condition can cause a severe allergic reaction to an ingredient in Maloprim called Dapsone. (Click here for more - May Require Free Registration
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.